Merck brings 11 presentations to BPI 2026 in Boston. Its program runs from continuous antibody processing through cell line and downstream development. Work covers hollow fiber countercurrent diafiltration, high-throughput convective chromatography for mRNA affinity purification, statistically validated smaller clone screening panels, and AI-assisted foam control in bioreactors.
| Organization | BPI 2026 Attendance |
|---|---|
Merck Rahway, New Jersey | 5 Senior Scientist · 2 Associate Principal Scientist · 1 Director · 1 R&D Information Architect and Data Strategy |
Global pharmaceutical company (Merck & Co., known as MSD outside the US and Canada) developing and manufacturing medicines, vaccines and biologics. | Chair Tue Sep 22 8:50am–9:00am Talk Tue Sep 22 1:00pm–1:30pm Talk Wed Sep 23 11:45am–12:15pm Talk Wed Sep 23 2:30pm–3:00pm Chair Thu Sep 24 11:25am–11:30am Chair Thu Sep 24 2:10pm–2:15pm Talk Thu Sep 24 4:30pm–5:00pm Talk Fri Sep 25 11:15am–11:45am Panel Fri Sep 25 11:45am–12:15pm Talk Fri Sep 25 2:30pm–3:30pm Talk Fri Sep 25 2:30pm–3:30pm |
Instantly find 20 buyers from Merck
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction